Prevalence of Metabolic Syndrome in Patients With Rheumatoid Arthritis: An Updated Systematic Review and Meta-Analysis

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 Apr 25

PMID 35462993

Authors

Wei Cai

Xuemi Tang

Min Pang

Affiliations

Soon will be listed here.

Abstract

Introduction: Rheumatoid arthritis (RA) due to systemic inflammation and insulin resistance increases the risk of cardiovascular disease and reduces life expectancy. In order to develop cardiac death prevention strategies, it is necessary to estimate the prevalence of metabolic syndrome (MetS) in these patients.

Methods: This systematic review and meta-analysis was performed to estimate the prevalence of MetS among patients with RA. International databases (i.e., Scopus, PubMed, Web of Science, and Google Scholar) were searched during the period of October 1 and October 10, 20121. Heterogeneity among the included studies was assessed through the Cochrane Q test statistics and I test. Finally, a random-effects meta-analysis model was computed to estimate the pooled prevalence of MetS.

Results: Sixty-one articles with 96 groups and a sample size of 13,644 people were analyzed. The pooled prevalence of MetS was 32% (95% CI: 29.6-34.4). The highest prevalence of MetS is related to studies conducted in Asia (32.7%, 95% CI: 29-36.3) and Europe (32.7%, 95% CI: 27.5.37.9) and the lowest Prevalence was also related to studies conducted in Africa (28%, 95% CI: 28.8-32.2). The prevalence of MetS in men was 33% (95% CI: 26-39) and 34% (95% CI: 29-40) in women. Findings by diagnostic criteria showed that the highest and lowest prevalence of MetS was related to ATP III (37.5%, 95% CI: 30.9-44.2) and EGIR (14.4%, 95% CI: 10.5-18.5), respectively.

Conclusions: MetS is highly prevalent in patients with RA and identification of high-risk patients is necessary to prevent cardiovascular mortality.

Citing Articles

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents.

Picchianti-Diamanti A, Aiello A, De Lorenzo C, Migliori G, Goletti D Front Immunol. 2025; 16:1494283.

PMID: 39963138 PMC: 11830708. DOI: 10.3389/fimmu.2025.1494283.

Prevalence of metabolic syndrome and its components according to altitude levels: a systematic review and meta-analysis.

Zila-Velasque J, Grados-Espinoza P, Challapa-Mamani M, Sanchez-Alcantara F, Cedillo-Balcazar J, Cs A Sci Rep. 2024; 14(1):27581.

PMID: 39528530 PMC: 11555074. DOI: 10.1038/s41598-024-77928-z.

Association between metabolic score for insulin resistance and cardiovascular disease mortality in patients with rheumatoid arthritis: evidence from the NHANES 1999-2018.

Zhou Y, Gao J Front Endocrinol (Lausanne). 2024; 15:1444800.

PMID: 39345880 PMC: 11427302. DOI: 10.3389/fendo.2024.1444800.

Identification of diagnostic genes and drug prediction in metabolic syndrome-associated rheumatoid arthritis by integrated bioinformatics analysis, machine learning, and molecular docking.

Huang Y, Yue S, Qiao J, Dong Y, Liu Y, Zhang M Front Immunol. 2024; 15:1431452.

PMID: 39139563 PMC: 11320606. DOI: 10.3389/fimmu.2024.1431452.

Association of the systemic immune-inflammation index with all-cause and cardiovascular mortality in individuals with rheumatoid arthritis.

Yin X, Zhang Y, Zou J, Yang J Sci Rep. 2024; 14(1):15129.

PMID: 38956376 PMC: 11219888. DOI: 10.1038/s41598-024-66152-4.

References

Agca R, Heslinga S, Rollefstad S, Heslinga M, McInnes I, Peters M . EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2016; 76(1):17-28. DOI: 10.1136/annrheumdis-2016-209775. View

de Oliveira B, das Chagas Medeiros M, Cerqueira J, de Souza Quixada R, Oliveira I . Metabolic syndrome in patients with rheumatoid arthritis followed at a University Hospital in Northeastern Brazil. Rev Bras Reumatol Engl Ed. 2016; 56(2):117-25. DOI: 10.1016/j.rbre.2015.08.016. View

Gomes K, Luz A, Felipe M, Beltrao L, Sampaio A, Rodrigues C . Prevalence of metabolic syndrome in rheumatoid arthritis patients from Northeastern Brazil: Association with disease activity. Mod Rheumatol. 2017; 28(2):258-263. DOI: 10.1080/14397595.2017.1316813. View

Mottillo S, Filion K, Genest J, Joseph L, Pilote L, Poirier P . The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56(14):1113-32. DOI: 10.1016/j.jacc.2010.05.034. View

Garcia-Chagollan M, Hernandez-Martinez S, Rojas-Romero A, Munoz-Valle J, Sigala-Arellano R, Cerpa-Cruz S . Metabolic syndrome in rheumatoid arthritis patients: Relationship among its clinical components. J Clin Lab Anal. 2020; 35(3):e23666. PMC: 7957969. DOI: 10.1002/jcla.23666. View

Kong C, Wang C, Niu K, Qi W . Prevalence of metabolic syndrome in patients with rheumatoid arthritis in eastern China-A hospital based study. Int J Rheum Dis. 2021; 24(9):1121-1126. DOI: 10.1111/1756-185X.14148. View

Muller R, Kull M, Polluste K, Aart A, Eglit T, Lember M . The metabolic profile in early rheumatoid arthritis: a high prevalence of metabolic obesity. Rheumatol Int. 2016; 37(1):21-27. DOI: 10.1007/s00296-016-3464-9. View

da Cunha V, Brenol C, Brenol J, Fuchs S, Arlindo E, Melo I . Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. Scand J Rheumatol. 2012; 41(3):186-91. DOI: 10.3109/03009742.2011.626443. View

Solomon A, Christian B, Norton G, Woodiwiss A, Dessein P . Risk factor profiles for atherosclerotic cardiovascular disease in black and other Africans with established rheumatoid arthritis. J Rheumatol. 2010; 37(5):953-60. DOI: 10.3899/jrheum.091032. View

10.

Hugo M, Mehsen-Cetre N, Pierreisnard A, Schaeverbeke T, Gin H, Rigalleau V . Energy expenditure and nutritional complications of metabolic syndrome and rheumatoid cachexia in rheumatoid arthritis: an observational study using calorimetry and actimetry. Rheumatology (Oxford). 2016; 55(7):1202-9. DOI: 10.1093/rheumatology/kew038. View

11.

Pandey P, Swami A, Biswas T, Thakuria R . Prevalence of Metabolic Syndrome in Treatment Naïve Rheumatoid Arthritis and Correlation With Disease Parameters. Arch Rheumatol. 2018; 32(1):46-52. PMC: 6190937. DOI: 10.5606/ArchRheumatol.2017.5949. View

12.

Karimi M, Mazloomzadeh S, Kafan S, Amirmoghadami H . The frequency of metabolic syndrome in women with rheumatoid arthritis and in controls. Int J Rheum Dis. 2011; 14(3):248-54. DOI: 10.1111/j.1756-185X.2011.01595.x. View

13.

Sahebari M, Goshayeshi L, Mirfeizi Z, Rezaieyazdi Z, Hatef M, Ghayour-Mobarhan M . Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis. ScientificWorldJournal. 2011; 11:1195-205. PMC: 5720084. DOI: 10.1100/tsw.2011.111. View

14.

Hallajzadeh J, Khoramdad M, Izadi N, Karamzad N, Almasi-Hashiani A, Ayubi E . Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. Menopause. 2018; 25(10):1155-1164. DOI: 10.1097/GME.0000000000001136. View

15.

Giles J, Allison M, Blumenthal R, Post W, Gelber A, Petri M . Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum. 2010; 62(11):3173-82. PMC: 2962724. DOI: 10.1002/art.27629. View

16.

Kuriya B, Schieir O, Valois M, Pope J, Boire G, Bessette L . Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid Arthritis. ACR Open Rheumatol. 2019; 1(9):535-541. PMC: 6858015. DOI: 10.1002/acr2.11075. View

17.

Ostojic P, Bartolovic D . Disease activity, obesity, functional disability, and depression in patients with rheumatoid arthritis : Impact on lipid status, glycoregulation, and risk for coronary heart disease. Z Rheumatol. 2015; 75(7):716-22. DOI: 10.1007/s00393-015-1661-7. View

18.

Shahin D, Eltoraby E, Mesbah A, Houssen M . Insulin resistance in early untreated rheumatoid arthritis patients. Clin Biochem. 2010; 43(7-8):661-5. DOI: 10.1016/j.clinbiochem.2010.01.012. View

19.

Tantayakom P, Koolvisoot A, Arromdee E, Chiowchanwisawakit P, Muangchan C, Katchamart W . Metabolic syndrome is associated with disease activity in patients with rheumatoid arthritis. Joint Bone Spine. 2016; 83(5):563-7. DOI: 10.1016/j.jbspin.2015.10.016. View

20.

Lo C, Mertz D, Loeb M . Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol. 2014; 14:45. PMC: 4021422. DOI: 10.1186/1471-2288-14-45. View